A tumor-specific antibody-LTα fusion protein has been shown to exhibit cytotoxic activity against syngeneic murine melanoma, accompanied by functional lymphoid organization comprising B and T cell aggregates, MHC class II+ antigen-presenting cells, L-selectin+ T cells, and PNAd+ high endothelial venules [55]. Here, NTAN1 is linked to melanoma.